Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device VCs Choose Flight, And Fight, In Face Of Challenges

This article was originally published in Start Up

Executive Summary

The entire venture capital industry is facing difficult times. But few are taking as hard a hit as medical device investors. In our survey of 100 institutional and corporate VCs, 65% of the venture capitalists who said they invest primarily in medical device companies say they’re feeling “negative” about “the current state and future of VC.” Only 17% say they feel positive, with the remainder feeling neutral. Not surprising, device VCs’ worries center around limited partners and the FDA. Limited partners are demanding strong returns before re-upping with new funds, and the FDA, while improving, is holding a firm line in issuing new approvals. Device VCs keep looking for innovative technologies and waiting for opportunities to improve.

Advertisement

Related Content

Device Investors Buoyed By Secondhand Optimism
Device Start-Ups Reap More Corporate Venture
Intersect Follows Leaders In ENT
Medtech Investing In Europe: Nowhere To Go But Up
No Obvious Prescription For Biopharma Investors
Corporate Venture Eyes The Early Stage
Life Science VCs: East Coast Vs. West Coast
The Renal Denervation Buzz: Separating Fact From Myth; Covidien Buys Maya Medical
Covidien Acquisitions Keeps Buying Spree Alive
Ascension Rises: Hospital Venture Group Gets More Muscle

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037822

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel